Reckitt Benckiser Group PLC (OTC:RBGPF) Earnings Report Highlights

• Earnings Per Share (EPS) matched the estimated at $2.49.
• Reported revenue was $9.78 billion, slightly below the estimated $9.79 billion.
• Projects like-for-like net revenue growth within the 4% to 5% range for 2026.

Reckitt Benckiser Group PLC, trading under the symbol RBGPF on the OTC exchange, is a global consumer goods company known for its popular brands like Dettol, Nurofen, and Durex. The company operates in the health, hygiene, and home product sectors, competing with other major players in the industry. Reckitt's diverse brand portfolio and extensive geographic reach contribute to its strong market presence.

On March 5, 2026, RBGPF reported its earnings, revealing an earnings per share (EPS) of $2.49, which matched the estimated EPS of $2.49. The company generated a revenue of approximately $9.78 billion, slightly below the estimated revenue of about $9.79 billion. Despite this minor shortfall, Reckitt's core business growth has surpassed its medium-term targets, signaling a strong performance in 2025.

Reckitt projects a like-for-like net revenue growth within the 4% to 5% range for 2026. This optimism is supported by a 5% increase in sales on a like-for-like basis compared to the previous year, driven by strong performance in emerging markets. CEO Kris Licht attributes the company's success to its extensive geographic reach, strong brand portfolio, and streamlined organizational structure.

The company's financial metrics provide further insight into its performance. With a price-to-earnings (P/E) ratio of approximately 33.54, investors are willing to pay a premium for each dollar of earnings. The price-to-sales ratio of about 2.82 and enterprise value to sales ratio of around 3.42 reflect Reckitt's market value relative to its sales and revenue.

Reckitt's enterprise value to operating cash flow ratio is approximately 19.02, highlighting its valuation in relation to cash flow from operations. The earnings yield of about 2.98% offers insight into the return on investment for shareholders. The debt-to-equity ratio of approximately 1.47 indicates the proportion of debt used to finance the company's assets, while the current ratio of around 0.56 suggests its ability to cover short-term liabilities with short-term assets.